New Delhi: With the passage of time technological advancements like In vitro fertilization (IVF) have led to tectonic shift in the management of female infertility However, despite the improvements made in the space, challenges associated with the treatment remain. The development of non-injectable fertility medications represents a significant unmet need, informed GlobalData, a data-analysis firm.Dr Shireen Mohammad, Senior Cardiovascular and Metabolic Disorders Analyst, GlobalData, said “While injectable gonadotropins are commonly used in IVF they require subcutaneous or intramuscular injections, which can be inconvenient, painful, and stressful for patients. Therefore, the development of non-injectable alternatives could offer significant benefits in terms of patient convenience, compliance, and the overall treatment experience.”
‘Addressing these unmet needs could significantly improve the success rates of infertility treatments, enhancing the chances of successful
pregnancies and improving the overall health and quality of life for women struggling with infertility,” Mohammad added.